SMS Lifesciences India Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 80.05 | 87.63 | 82.94 |
| Operating Expense | 68.21 | 79.83 | 69.81 |
| Net Profit | 5.16 | 2.68 | 6.23 |
| Net Profit Margin | 6.45 | 3.06 | 7.51 |
| Earning Per Share | 17.06 | 8.85 | 20.60 |
| EBIDTA | 11.77 | 8.14 | 13.06 |
| Effective Tax Rate | 18.99 | 12.82 | 17.59 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 80.05 |
| Operating Expense | 68.21 |
| Net Profit | 5.16 |
| Net Profit Margin | 6.45 |
| Earning Per Share | 17.06 |
| EBIDTA | 11.77 |
| Effective Tax Rate | 18.99 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 333.37 | 300.00 | 315.24 |
| Operating Expenses Annual | 289.14 | 265.57 | 288.84 |
| Operating Profit Annual | 48.18 | 38.27 | 31.64 |
| Interest Annual | 7.88 | 8.90 | 5.09 |
| Depreciation | 9.59 | 9.56 | 7.53 |
| Net Profit Annual | 21.37 | 13.07 | 13.22 |
| Tax Annual | 8.67 | 6.05 | 5.15 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 333.37 |
| Operating Expenses Annual | 289.14 |
| Operating Profit Annual | 48.18 |
| Interest Annual | 7.88 |
| Depreciation | 9.59 |
| Net Profit Annual | 21.37 |
| Tax Annual | 8.67 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.33 | 0.15 | 0.95 |
| Cash Flow from Operations | 28.03 | 14.75 | 4.58 |
| Cash Flow from Investing | -13.77 | -13.75 | -27.96 |
| Cash Flow from Financing | -14.20 | -0.82 | 22.59 |
| Cash Flow at the End | 0.40 | 0.33 | 0.15 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 0.33 |
| Cash Flow from Operations | 28.03 |
| Cash Flow from Investing | -13.77 |
| Cash Flow from Financing | -14.20 |
| Cash Flow at the End | 0.40 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 13.10 | 11.67 | 8.25 |
| PBIT Margin (%) | 10.31 | 8.56 | 5.93 |
| PBT Margin (%) | 9.01 | 7.61 | 4.78 |
| Net PROFIT Margin (%) | 5.80 | 3.98 | 3.76 |
| Return On Networth / Equity (%) | 11.45 | 7.68 | 7.20 |
| Return On Networth /Employed (%) | 13.69 | 10.68 | 8.85 |
| Return On Assets (%) | 7.72 | 4.97 | 5.60 |
| Total Debt / Equity (X) | 0.46 | 0.53 | 0.47 |
| Asset Turnover Ratio (%) | 1.33 | 1.25 | 1.49 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 13.10 |
| PBIT Margin (%) | 10.31 |
| PBT Margin (%) | 9.01 |
| Net PROFIT Margin (%) | 5.80 |
| Return On Networth / Equity (%) | 11.45 |
| Return On Networth /Employed (%) | 13.69 |
| Return On Assets (%) | 7.72 |
| Total Debt / Equity (X) | 0.46 |
| Asset Turnover Ratio (%) | 1.33 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 150.23 | 138.23 | 139.61 |
| Total Current Assets Annual | 177.79 | 175.35 | 167.59 |
| Non Current Assets Annual | 180.52 | 172.88 | 169.80 |
| Total Shareholders Funds Annual | 197.18 | 176.23 | 164.03 |
| Total Assets Annual | 358.31 | 348.24 | 337.39 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 150.23 |
| Total Current Assets Annual | 177.79 |
| Non Current Assets Annual | 180.52 |
| Total Shareholders Funds Annual | 197.18 |
| Total Assets Annual | 358.31 |
EPS (INR)
Expected
13.77
Reported
13.75
Surprise
-0.15%
Mar 2025
EPS beaten by -0.15%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by -0.17%
